Newborn Screening Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) has awarded a sole-source Blanket Purchase Agreement (BPA) to the Oregon Health Authority (OHA) for comprehensive newborn metabolic screening services. This BPA will support five overseas Military Treatment Facilities (MTFs) in the Indo-Pacific region and is valued at an estimated $4,545,880.00.
Scope of Work
The Oregon Health Authority (OHA) will provide comprehensive newborn metabolic screening services, including testing for a wide range of disorders such as organic acidemias, fatty acid oxidation disorders, amino acid disorders, endocrine disorders, lysosomal storage diseases, Cystic fibrosis, Biotinidase deficiency, Classic galactosemia, hemoglobinopathies, Severe Combined Immunodeficiency disease (SCID), Spinal Muscular Atrophy, and X-linked Adrenal Leukodystrophy (XALD). OHA will also supply necessary testing materials (e.g., newborn screening cards and envelopes), provide website access for patient test results, and ensure immediate notification of abnormal results to MTFs.
Contract & Timeline
- Contract Type: Firm-Fixed-Price (FFP) per newborn screening test ordered.
- Period of Performance: A base period from April 1, 2026, to March 31, 2027, with four subsequent option periods, extending the total performance through March 31, 2031.
- Estimated Value: $4,545,880.00 (Total for Base Period and all Option Periods).
- Payment Method: Government Commercial Purchase Card (GCPC).
- Set-Aside: None (Sole Source).
- Award Notice Published: March 10, 2026.
Justification for Sole Source
The award to OHA was justified under 41 U.S.C. § 1901 and FAR 12.102(b), allowing solicitation from one source for commercial services not exceeding the simplified acquisition threshold. OHA was identified as the only reasonably available source due to its proven performance, unique logistical advantages (geographic proximity and time zone to the Indo-Pacific MTFs), and a demonstrated lack of interest from other potential sources. Market research, including a Notice of Intent/Sources Sought on SAM.gov, yielded zero responses.
Key Considerations
This is a sole-source award, indicating no open competition for this specific requirement. The BPA consolidates services previously provided separately to the five MTFs. Future competition may be sought after this BPA expires, following further market research by the Defense Health Agency (DHA) Contracting Activity (DHACA), Healthcare Contracting Division (HCD) - West.